Rd. White et al., INDUCTION AND POSTTRANSCRIPTIONAL SUPPRESSION OF HEPATIC CYTOCHROME-P450 1A1 BY 3,3',4,4'-TETRACHLOROBIPHENYL, Biochemical pharmacology, 53(7), 1997, pp. 1029-1040
3,3',4,4'-Tetrachlorobiphenyl (TCB) can induce and inhibit cytochrome
P450 1A1 (CYF1A1) in vertebrates. TCB may also suppress CYP1A1 protein
levels, but the mechanism is unknown. This study examined transcripti
onal and translational aspects of hepatic CYP1A1 regulation in the fis
h scup (Stenotomus chrysops) given single intraperitoneal injections o
f low (0.1 mg/kg) or high (5 mg/kg) doses of TCB, and sampled over 16
days. The low dose strongly induced hepatic CYP1A1 mRNA (25-fold), pro
tein (12-fold), and activity [ethoxyresorufin O-deethylase (EROD)] (15
-fold). The high dose also strongly induced CYP1A1 mRNA (29-fold), in
a pattern like that at the low dose, but microsomal CYP1A1 protein con
tent was induced only 4-fold and EROD rates were near control levels.
Both TCB doses caused similar increases in microsomal cytochrome b(5)
content, and in rates of NADPH-cytochrome c (P450) reductase and UDP-g
lucuronosyltransferase (with p-nitrophenol). The contents of CYP forms
other than CYP1A1 (putative CYP2B or CYP3A) were only weakly affected
by TCB at either dose. The strong and largely specific post-transcrip
tional suppression of CYP1A1 content was associated with high concentr
ations of TCB measured in the liver. Incubation of scup hepatic micros
omes with TCB plus NADPH led to a time-dependent inactivation of CYP1A
1 that was distinct from catalytic inhibition, and appeared not to inv
olve reactive metabolites of TCB. This in vitro result suggests that T
CB may inactivate CYP1A1 in vivo, which could account for the apparent
antagonistic effect of TCB on CYP1A1 induction. (C) 1997 Elsevier Sci
ence Inc.